Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
1-10
employees, estimated range
Backers
1
Bm T
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
Legal entity DeepEn GmbH its site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Manifold Bio11-50 employees • 7 roles
Manifold Bio has built the first high-throughput in vivo (HTV) discovery engine—combining massively multiplexed in vivo screening and…
PiramidalFounded 2024 • 1-10 employees • 2 roles
PIRAMIDAL. Bridge in-vivo with in-silico intelligence.
Stylus Medicine, Inc. is a biotechnology company dedicated to developing transformative in vivo genetic medicines.
Immitra BioVenture round $2.7M · 2 mo ago • 11-50 employees
Developing scalable in-vivo genomic medicine for blood disorders.
Mammoth Biosciences201-500 employees • 1 role
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Vivacta bioSeries A · 5 mo ago
微滔生物成立于2025年6月25日,其前身系沙砾集团为自主研发的体内CAR-T平台独立运营而成。微滔生物将基于T 靶向 LNP 递送系统开发in vivo CAR-T管线,专注于非病毒体内靶向细胞治疗业务,该业务主要用于血液瘤及自身免疫疾病治疗。.

Overview

DeepEn One™ in vivo Microendoscopy Platform. Single-Fibre Endoscope for High-Resolution In Vivo Bioimaging.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1